Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Globus Medical Inc (GMED)

Globus Medical Inc (GMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Globus Medical Inc 2560 GENERAL ARMISTEAD AVENUE AUDUBON PA 19403 USA

www.globusmedical.com P: 610-930-1800 F: 610-930-2042

Description:

Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.

Key Statistics

Overview:

Market Capitalization, $K 6,940,523
Enterprise Value, $K 6,890,633
Shares Outstanding, K 135,372
Annual Sales, $ 1,568 M
Annual Net Income, $ 122,870 K
Last Quarter Sales, $ 616,530 K
Last Quarter Net Income, $ 15,030 K
EBIT, $ 184,180 K
EBITDA, $ 409,540 K
60-Month Beta 1.08
% of Insider Shareholders 24.30%
% of Institutional Shareholders 95.16%
Float, K 102,477
% Float 75.70%
Short Volume Ratio 0.60

Growth:

1-Year Return -11.45%
3-Year Return -28.33%
5-Year Return 18.80%
5-Year Revenue Growth 119.99%
5-Year Earnings Growth 38.92%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.60 on 02/20/24
Latest Earnings Date 05/07/24
Earnings Per Share ttm 2.33
EPS Growth vs. Prev Qtr 5.26%
EPS Growth vs. Prev Year 1.69%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

GMED Ratios

Ratio
Price/Earnings ttm 22.00
Price/Earnings forward 18.70
Price/Earnings to Growth 1.48
Return-on-Equity % 8.82%
Return-on-Assets % 7.20%
Profit Margin % 7.83%
Debt/Equity 0.10
Price/Sales 6.80
Price/Cash Flow 13.96
Price/Book 1.72
Book Value/Share 29.32
Interest Coverage -1.23
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar